NCT04994704View on ClinicalTrials.gov

Comparison of Postoperative QoR-15 Scores Between Propofol and Remimazolam

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

July 12, 2023

Study Completion Date

July 12, 2023

Conditions
Patients Undergoing Spine Surgery
Interventions
DRUG

Propfol group

Propfol group will be started and maintained total intravenous anesthesia with propofol and remifentanil under target controlled infusion (TCI) model.

DRUG

Remimazolam group

Remimazolam group will be started total intravenous anesthesia with remiamazolam at 6 mg/kg/h for induction, and maintained at 0.5-1.5 mg/kg/h and remifentanil under TCI model.

Trial Locations (1)

Unknown

GangnamSeverance Hospital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT04994704 - Comparison of Postoperative QoR-15 Scores Between Propofol and Remimazolam | Biotech Hunter | Biotech Hunter